Cargando…

Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users

BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migrai...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Yuji, Poh, Weijie, Horvath, Zsolt, Cadiou, François, Shimazu, Tomokazu, Maruki, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426333/
https://www.ncbi.nlm.nih.gov/pubmed/34503456
http://dx.doi.org/10.1186/s12883-021-02378-3
_version_ 1783750021737349120
author Kato, Yuji
Poh, Weijie
Horvath, Zsolt
Cadiou, François
Shimazu, Tomokazu
Maruki, Yuichi
author_facet Kato, Yuji
Poh, Weijie
Horvath, Zsolt
Cadiou, François
Shimazu, Tomokazu
Maruki, Yuichi
author_sort Kato, Yuji
collection PubMed
description BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migraine in users residing in the United States. METHODS: Migraine Buddy is a smartphone application by individuals to record their migraine headache episodes, characteristics, and coping mechanisms. For this study, anonymized self-reported data from 163,176 adult Migraine Buddy users in the United States between January 2020 and May 2020, were analyzed for migraines associated with stress. A stress-related migraine is defined as one in which stress or anxiety was reported as a trigger or symptom. A questionnaire on the impact of COVID-19 on migraine and its management was also completed by 923 users from the United States in the app between April 2020 and May 2020. RESULTS: 88% of the Migraine Buddy database extract and 84% of the respondents are female, with a mean age of 36.2 years. The proportion of stress-related migraine attacks peaked at 53% on March 21 to 23, although the number of migraine attacks decreased. This followed the declaration of the COVID-19 national emergency on March 13 and a spike in the number of COVID-19 cases in the United States. Questionnaire respondents felt that the following added more stress: social isolation (22.6%), information overdose (21.2%), access to essentials (food, medication, etc.) (18.7%), and financial concerns (17.8%). To help manage migraine during COVID-19, respondents suggested stress and diet coaching programs and resources (medical articles, etc.) (34.0%), having the option for home delivery of medication (30.6%) and tele-consulting (25.5%). CONCLUSION: Here, we report the change in the proportion of self-reported stress-related migraine in relation to evolution of the COVID-19 pandemic, as well as its impact of migraine management. Our data will help increase the understanding of patients’ needs and help with planning and execution of mitigating strategies.
format Online
Article
Text
id pubmed-8426333
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84263332021-09-09 Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users Kato, Yuji Poh, Weijie Horvath, Zsolt Cadiou, François Shimazu, Tomokazu Maruki, Yuichi BMC Neurol Research Article BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migraine in users residing in the United States. METHODS: Migraine Buddy is a smartphone application by individuals to record their migraine headache episodes, characteristics, and coping mechanisms. For this study, anonymized self-reported data from 163,176 adult Migraine Buddy users in the United States between January 2020 and May 2020, were analyzed for migraines associated with stress. A stress-related migraine is defined as one in which stress or anxiety was reported as a trigger or symptom. A questionnaire on the impact of COVID-19 on migraine and its management was also completed by 923 users from the United States in the app between April 2020 and May 2020. RESULTS: 88% of the Migraine Buddy database extract and 84% of the respondents are female, with a mean age of 36.2 years. The proportion of stress-related migraine attacks peaked at 53% on March 21 to 23, although the number of migraine attacks decreased. This followed the declaration of the COVID-19 national emergency on March 13 and a spike in the number of COVID-19 cases in the United States. Questionnaire respondents felt that the following added more stress: social isolation (22.6%), information overdose (21.2%), access to essentials (food, medication, etc.) (18.7%), and financial concerns (17.8%). To help manage migraine during COVID-19, respondents suggested stress and diet coaching programs and resources (medical articles, etc.) (34.0%), having the option for home delivery of medication (30.6%) and tele-consulting (25.5%). CONCLUSION: Here, we report the change in the proportion of self-reported stress-related migraine in relation to evolution of the COVID-19 pandemic, as well as its impact of migraine management. Our data will help increase the understanding of patients’ needs and help with planning and execution of mitigating strategies. BioMed Central 2021-09-09 /pmc/articles/PMC8426333/ /pubmed/34503456 http://dx.doi.org/10.1186/s12883-021-02378-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kato, Yuji
Poh, Weijie
Horvath, Zsolt
Cadiou, François
Shimazu, Tomokazu
Maruki, Yuichi
Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title_full Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title_fullStr Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title_full_unstemmed Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title_short Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
title_sort impact of covid-19 pandemic on migraine management in the united states: insights from migraine tracking app users
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426333/
https://www.ncbi.nlm.nih.gov/pubmed/34503456
http://dx.doi.org/10.1186/s12883-021-02378-3
work_keys_str_mv AT katoyuji impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers
AT pohweijie impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers
AT horvathzsolt impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers
AT cadioufrancois impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers
AT shimazutomokazu impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers
AT marukiyuichi impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers